CVE-2025-58132

CVE-2025-58132 is a medium-severity vulnerability in Zoom Meeting Software Development Kit with a CVSS 3.x base score of 4.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-77.

Key facts

Description

Command injection in some Zoom Clients for Windows may allow an authenticated user to conduct a disclosure of information via network access.

Frequently asked questions

What is CVE-2025-58132?
Command injection in some Zoom Clients for Windows may allow an authenticated user to conduct a disclosure of information via network access.
How severe is CVE-2025-58132?
CVE-2025-58132 has a CVSS 3.x base score of 4.1, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity none, and availability none.
Is CVE-2025-58132 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (77th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-58132?
CVE-2025-58132 primarily affects Zoom Meeting Software Development Kit. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2025-58132?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-58132 have an EU (EUVD) identifier?
Yes. CVE-2025-58132 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-34670.
When was CVE-2025-58132 published?
CVE-2025-58132 was published on 2025-10-15 and last updated on 2026-06-17.

References

Affected products (4)

More vulnerabilities in Zoom Meeting Software Development Kit

All CVEs affecting Zoom Meeting Software Development Kit →

Other CWE-77 (Command Injection) vulnerabilities

Browse all CWE-77 (Command Injection) vulnerabilities →